Anti-BMAL1 mAb-Discontinued (Monoclonal Antibody) (Discontinued)
|RbAp48 Polyclonal Antibody.





Specifications:
Description
We are sorry for the inconvenience; this product code has been discontinued.
This product has been discontinued.
|Polyclonal antibody of 100 μl targeting RbAp48 for ICC, IHC, WB.
Target: | RbAp48 |
---|---|
Product Type: | Antibody |
Size: | -, 100 µl |
Application: | ICC |
Conjugate: | Unlabeled |
Antibody Type: | Polyclonal |
Formulation: | |50 µg IgG in 100 µl volume of PBS containing 50% glycerol, pH 7.2. Contains no preservatives. |
Isotype: | IgG |
Immunogen: | |Synthetic peptide (1-14 aa of human RbAp48) (MADKEAAFDDAVEEC) |
Host Species: | Rabbit |
Species Reactivity: | Hamster |
Source: | |This antibody was an Protein A column chromatography purified rabbit polyclonal antibody raised against synthesized peptide, MADKEAAFDDAVEEC, which corresponding to human RbAp48 (1-14 aa). |
Reactivity: | |This antibody reacts with human, mouse, rat and hamster RbAp48 (60 kDa) on Western blotting. |
Gene ID Human: | | |
Gene ID Mouse: | | |
Gene ID Rat: | |
Storage Temperature: | | -20°C |
Regulatory Statement: | |For Research Use Only. Not for use in diagnostic procedures. |
Citations
|
- Honda H et al. Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients. Atherosclerosis. 220, 493-501 (2012),
- Tarakida A et al. Hypercholesterolemia accelerates bone loss in postmenopausal women. Climacteric. 14, 105-11 (2011),
- Yamaoka-Tojo M et al. Circulating interleukin-18: A specific biomarker for atherosclerosis-prone patients with metabolic syndrome. Nutr Metab (Lond). 8, 3 (2011)